Myocardial Function of the Setonis Aortic Valve Before and Beyond Valve Replacement
NCT ID: NCT03686527
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
277 participants
OBSERVATIONAL
2018-01-11
2019-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
NCT02023060
Assessment of Right Ventricular Function in Patients With Severe Mitral Stenosis Before and After Balloon Mitral Valvuloplasty
NCT06067815
Aortic Stenosis: Determinants and Prognostic Value of Preoperative Left Ventricular Remodeling After Valvular Replacement
NCT03411304
Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice
NCT03453567
Clinical Outcome of Patients With Low-gradient Severe Aortic Stenosis
NCT02010177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Echocardiography
stenosis aortic valve
The exams to be realized :
* a clinical examination with blood pressure
* a 12-lead surface electrocardiogram
* a standard biological assessment including NTproBNP (Brain Natriuretic Peptide)
* Transthoracic echocardiography at baseline and 12 months after the aortic valve intervention on the (according to recommendations)
* a cardiac MRI looking for fibrosis myocardial
MRI Fibrosis
stenosis aortic valve
The exams to be realized :
* a clinical examination with blood pressure
* a 12-lead surface electrocardiogram
* a standard biological assessment including NTproBNP (Brain Natriuretic Peptide)
* Transthoracic echocardiography at baseline and 12 months after the aortic valve intervention on the (according to recommendations)
* a cardiac MRI looking for fibrosis myocardial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stenosis aortic valve
The exams to be realized :
* a clinical examination with blood pressure
* a 12-lead surface electrocardiogram
* a standard biological assessment including NTproBNP (Brain Natriuretic Peptide)
* Transthoracic echocardiography at baseline and 12 months after the aortic valve intervention on the (according to recommendations)
* a cardiac MRI looking for fibrosis myocardial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-opposition signed
* aortic surface \<1cm² or \<0.6cm² / m² of indication surgical restraint
* oriented to short interventional management surgical term
* LVEF Left ventricular ejection fraction\> 50%
* In the subgroup "MRI-fibrosis", absence of indication for performing MRI
Exclusion Criteria
* minor patient
* pregnant woman
* patient with significant polyvalvulopathy for which it is from the start programmed more than aortic valve replacement
* patient with severe coronary artery disease requiring revascularization
* allergy to the contrast product
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Rennes
Rennes, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35RC12_8974 AOMYOC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.